0001997296 2025-12-19 2025-12-19 0001997296 1 2025-12-19 2025-12-19 0001997296 2 2025-12-19 2025-12-19 0001997296 3 2025-12-19 2025-12-19 0001997296 4 2025-12-19 2025-12-19 0001997296 5 2025-12-19 2025-12-19 0001997296 6 2025-12-19 2025-12-19 0001997296 7 2025-12-19 2025-12-19 iso4217:USD pure S-3 S-3 EX-FILING FEES 0001997296 Medicus Pharma Ltd. N/A N/A 0.0001381 S-3 Medicus Pharma Ltd. false Equity Common share, no par value true 0.00 0.0001381 0.00 false Equity Preferred shares, no par value true 0.00 0.0001381 0.00 false Other Warrants true 0.00 0.0001381 0.00 false Other Units true 0.00 0.0001381 0.00 false Other Subscription rights true 0.00 0.0001381 0.00 false Other Unallocated (Universal) Shelf true 100000000.00 false Unallocated (Universal) Shelf true 100000000.00 0.0001381 13810.00 100000000.00 13810.00 0.00 0.00 13810.00 There are being registered pursuant to the registration statement such indeterminate number of (a) common shares, no par value ("common shares"), (b) preferred shares, no par value ("preferred shares"), (c) warrants to purchase common shares or preferred shares of the registrant, (d) subscription rights to purchase common shares, preferred shares, warrants or units consisting of some or all of these securities of the registrant, and (e) units consisting of some or all of these securities, as may be offered from time to time pursuant to the prospectus contained in the registration statement with an aggregate initial offering price not to exceed $100,000,000, or the equivalent thereof in foreign currencies. There are also being registered under the registration statement an indeterminate amount or number of shares of the securities as may be issuable upon conversion or exchange of warrants or pursuant to antidilution provisions thereof or offered or issued from share splits, share dividends, recapitalizations or similar transactions. The proposed maximum per unit and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered under the registration statement and is not specified as to each class of security pursuant to Instruction 2.A.iii.b of the Instructions to the Calculation of Filing Fee Tables and Related Disclosure of Form S-3. The registration fee has been calculated in accordance with Rule 457(o) under the Securities Act. Any securities registered under the registration statement may be sold separately or as units with other securities registered under the registration statement.